Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shusuke Yoshikawa

Showing results (1-10 of 74) with videos related to

Pageof 8
Sort By:
International Journal of Surgical Pathology|February 27, 2023
Carcinoid-Like Cell Arrangements in Basal Cell Carcinoma: A Study of 11 CasesKeisuke Goto, Takuma Oishi, Shusuke Yoshikawa
International Journal of Clinical Oncology|August 1, 2013
Accuracy of real-time ultrasound elastography in the differential diagnosis of lymph nodes in cutaneous malignant melanoma (CMM): a pilot studyDai Ogata, Takayoshi Uematsu, Shusuke Yoshikawa, et al.
International Journal of Clinical Oncology|August 1, 2013
Treatment strategy for cutaneous apocrine carcinomaDai Ogata, Yoshio Kiyohara, Shusuke Yoshikawa, et al.
The Journal of Dermatology|September 6, 2025
Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 MonotherapyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
The Journal of Dermatology|March 5, 2025
Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective studyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
The American Journal of Dermatopathology|November 23, 2007
Large-cell neuroendocrine carcinoma of the skin, with lymphoid stromaMasako Kasami, Kouji Muramatsu, Kazuhiro Kawahata, et al.
The Journal of Dermatology|May 5, 2026
Melanoma Dissemination Through Bullous Solar Elastosis: Previously Undescribed Pattern of Cancer DisseminationKen Horisaki, Keisuke Goto, Arata Tsutsumida, et al.
The Journal of Dermatology|October 7, 2025
C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort StudyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
The Journal of Dermatology|January 7, 2026
Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective StudyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
Melanoma Research|December 4, 2024
Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort studyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
Pageof 8

Showing results (1-10 of 74) with videos related to

Sort By:
Pageof 8
International Journal of Surgical Pathology|February 27, 2023
Carcinoid-Like Cell Arrangements in Basal Cell Carcinoma: A Study of 11 CasesKeisuke Goto, Takuma Oishi, Shusuke Yoshikawa
International Journal of Clinical Oncology|August 1, 2013
Accuracy of real-time ultrasound elastography in the differential diagnosis of lymph nodes in cutaneous malignant melanoma (CMM): a pilot studyDai Ogata, Takayoshi Uematsu, Shusuke Yoshikawa, et al.
International Journal of Clinical Oncology|August 1, 2013
Treatment strategy for cutaneous apocrine carcinomaDai Ogata, Yoshio Kiyohara, Shusuke Yoshikawa, et al.
The Journal of Dermatology|September 6, 2025
Prognosis and Toxicity Stratified by Best Tumor Burden Change in Japanese Patients With Advanced Melanoma Treated With First-Line Programmed Cell Death Protein 1 MonotherapyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
The Journal of Dermatology|March 5, 2025
Comparison of efficacy and adverse events by treatment cycles of nivolumab and ipilimumab in Japanese melanoma patients: A single-center, retrospective studyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
The American Journal of Dermatopathology|November 23, 2007
Large-cell neuroendocrine carcinoma of the skin, with lymphoid stromaMasako Kasami, Kouji Muramatsu, Kazuhiro Kawahata, et al.
The Journal of Dermatology|May 5, 2026
Melanoma Dissemination Through Bullous Solar Elastosis: Previously Undescribed Pattern of Cancer DisseminationKen Horisaki, Keisuke Goto, Arata Tsutsumida, et al.
The Journal of Dermatology|October 7, 2025
C-Reactive Protein Kinetics as Prognostic Biomarkers in Stage IV-Melanoma Treated With Immune Checkpoint Inhibitors in the Japanese Population: A Single-Center, Retrospective Cohort StudyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
The Journal of Dermatology|January 7, 2026
Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective StudyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
Melanoma Research|December 4, 2024
Clinical features of vulvar and vaginal malignant melanomas and the effects of immune checkpoint inhibitors in Japanese patients: a single-center, retrospective cohort studyKen Horisaki, Shusuke Yoshikawa, Wataru Omata, et al.
Pageof 8